Press release
Follicle Stimulating Hormone Market size was US$ 1357.7 million and is forecast to US$ 1816.7 million in 2026, growing at a CAGR of 4.2% from 2020
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Follicle Stimulating Hormone Industry Research Report, Growth Trends and Competitive Analysis 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Follicle Stimulating Hormone market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Follicle Stimulating Hormone market.
The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Follicle Stimulating Hormone market.
Top Companies/Manufacturers:
Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter, Teva
Market Segment by Product Type: Recombinant FSH, Urinary FSH
Market Segment by Application: Infertility Treatment, Assisted Reproductive Technology
Get PDF Sample Copy of the Report @
https://www.qyresearch.com/sample-form/form/1499486/global-follicle-stimulating-hormone-industry
For Discount, Customization in the Report Drop Your Query Here:
https://www.qyresearch.com/customize-request/form/1499486/global-follicle-stimulating-hormone-industry
Buy Now:
https://www.qyresearch.com/settlement/pre/99c0ac4f20aa497908e4732a03b224fa,0,1,global-follicle-stimulating-hormone-industry
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Follicle Stimulating Hormone market.
Key questions answered in the report:
What is the growth potential of the Follicle Stimulating Hormone market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Follicle Stimulating Hormone industry in the years to come?
What are the key challenges that the global Follicle Stimulating Hormone market may face in the future?
Which are the leading companies in the global Follicle Stimulating Hormone market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Follicle Stimulating Hormone market
TOC
Table of Contents 1 Report Overview
1.1 Research Scope
1.2 Top Follicle Stimulating Hormone Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Follicle Stimulating Hormone Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Recombinant FSH
1.3.3 Urinary FSH
1.4 Market Segment by Application
1.4.1 Global Follicle Stimulating Hormone Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Infertility Treatment
1.4.3 Assisted Reproductive Technology
1.5 Study Objectives
1.6 Years Considered 2 Global Market Perspective
2.1 Global Follicle Stimulating Hormone Revenue (2015-2026)
2.1.1 Global Follicle Stimulating Hormone Revenue (2015-2026)
2.1.2 Global Follicle Stimulating Hormone Sales (2015-2026)
2.2 Follicle Stimulating Hormone Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Follicle Stimulating Hormone Sales by Regions (2015-2020)
2.2.2 Global Follicle Stimulating Hormone Revenue by Regions (2015-2020)
2.3 Global Top Follicle Stimulating Hormone Regions (Countries) Ranking by Market Size
2.4 Follicle Stimulating Hormone Industry Trends
2.4.1 Follicle Stimulating Hormone Market Top Trends
2.4.2 Market Drivers
2.4.3 Follicle Stimulating Hormone Market Challenges 2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Follicle Stimulating Hormone Players: Views for Future 3 Competitive Landscape by Manufacturers
3.1 Global Top Follicle Stimulating Hormone Manufacturers by Sales (2015-2020)
3.1.1 Global Follicle Stimulating Hormone Sales by Manufacturers (2015-2020)
3.1.2 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Follicle Stimulating Hormone Sales in 2019
3.2 Global Top Manufacturers Follicle Stimulating Hormone by Revenue
3.2.1 Global Follicle Stimulating Hormone Revenue by Manufacturers (2015-2020)
3.2.2 Global Follicle Stimulating Hormone Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Follicle Stimulating Hormone Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicle Stimulating Hormone as of 2019)
3.4 Global Follicle Stimulating Hormone Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Follicle Stimulating Hormone Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Follicle Stimulating Hormone Market
3.7 Key Manufacturers Follicle Stimulating Hormone Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type
4.1 Global Follicle Stimulating Hormone Historic Market Review by Type (2015-2020)
4.1.2 Global Follicle Stimulating Hormone Sales Market Share by Type (2015-2020)
4.1.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2015-2020)
4.1.4 Follicle Stimulating Hormone Price by Type (2015-2020)
4.1 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Follicle Stimulating Hormone Sales Forecast by Type (2021-2026)
4.2.3 Global Follicle Stimulating Hormone Revenue Forecast by Type (2021-2026)
4.2.4 Follicle Stimulating Hormone Price Forecast by Type (2021-2026) 5 Global Follicle Stimulating Hormone Market Size by Application
5.1 Global Follicle Stimulating Hormone Historic Market Review by Application (2015-2020)
5.1.2 Global Follicle Stimulating Hormone Sales Market Share by Application (2015-2020)
5.1.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2015-2020)
5.1.4 Follicle Stimulating Hormone Price by Application (2015-2020)
5.2 Global Follicle Stimulating Hormone Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Follicle Stimulating Hormone Sales Forecast by Application (2021-2026)
5.2.3 Global Follicle Stimulating Hormone Revenue Forecast by Application (2021-2026)
5.2.4 Follicle Stimulating Hormone Price Forecast by Application (2021-2026) 6 North America
6.1 North America Follicle Stimulating Hormone Breakdown Data by Company
6.2 North America Follicle Stimulating Hormone Breakdown Data by Type
6.3 North America Follicle Stimulating Hormone Breakdown Data by Application
6.4 North America Follicle Stimulating Hormone Breakdown Data by Countries
6.4.1 North America Follicle Stimulating Hormone Sales by Countries
6.4.2 North America Follicle Stimulating Hormone Revenue by Countries
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Follicle Stimulating Hormone Breakdown Data by Company
7.2 Europe Follicle Stimulating Hormone Breakdown Data by Type
7.3 Europe Follicle Stimulating Hormone Breakdown Data by Application
7.4 Europe Follicle Stimulating Hormone Breakdown Data by Countries
7.4.1 Europe Follicle Stimulating Hormone Sales by Countries
7.4.2 Europe Follicle Stimulating Hormone Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia 8 Asia Pacific
8.1 Asia Pacific Follicle Stimulating Hormone Breakdown Data by Company
8.2 Asia Pacific Follicle Stimulating Hormone Breakdown Data by Type
8.3 Asia Pacific Follicle Stimulating Hormone Breakdown Data by Application
8.4 Asia Pacific Follicle Stimulating Hormone Breakdown Data by Regions
8.4.1 Asia Pacific Follicle Stimulating Hormone Sales by Regions
8.4.2 Asia Pacific Follicle Stimulating Hormone Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam 9 Latin America
9.1 Latin America Follicle Stimulating Hormone Breakdown Data by Company
9.2 Latin America Follicle Stimulating Hormone Breakdown Data by Type
9.3 Latin America Follicle Stimulating Hormone Breakdown Data by Application
9.4 Latin America Follicle Stimulating Hormone Breakdown Data by Countries
9.4.1 Latin America Follicle Stimulating Hormone Sales by Countries
9.4.2 Latin America Follicle Stimulating Hormone Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina 10 Middle East and Africa
10.1 Middle East and Africa Follicle Stimulating Hormone Breakdown Data by Type
10.2 Middle East and Africa Follicle Stimulating Hormone Breakdown Data by Application
10.3 Middle East and Africa Follicle Stimulating Hormone Breakdown Data by Countries
10.3.1 Middle East and Africa Follicle Stimulating Hormone Sales by Countries
10.3.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E 11 Company Profiles
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Merck Serono Follicle Stimulating Hormone Products and Services
11.1.5 Merck Serono SWOT Analysis
11.1.6 Merck Serono Recent Developments
11.2 MSD
11.2.1 MSD Corporation Information
11.2.2 MSD Business Overview and Total Revenue (2019 VS 2018)
11.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 MSD Follicle Stimulating Hormone Products and Services
11.2.5 MSD SWOT Analysis
11.2.6 MSD Recent Developments
11.3 IBSA
11.3.1 IBSA Corporation Information
11.3.2 IBSA Business Overview and Total Revenue (2019 VS 2018)
11.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 IBSA Follicle Stimulating Hormone Products and Services
11.3.5 IBSA SWOT Analysis
11.3.6 IBSA Recent Developments
11.4 Ferring
11.4.1 Ferring Corporation Information
11.4.2 Ferring Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Ferring Follicle Stimulating Hormone Products and Services
11.4.5 Ferring SWOT Analysis
11.4.6 Ferring Recent Developments
11.5 Livzon
11.5.1 Livzon Corporation Information
11.5.2 Livzon Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Livzon Follicle Stimulating Hormone Products and Services
11.5.5 Livzon SWOT Analysis
11.5.6 Livzon Recent Developments
11.6 Techwell
11.6.1 Techwell Corporation Information
11.6.2 Techwell Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Techwell Follicle Stimulating Hormone Products and Services
11.6.5 Techwell SWOT Analysis
11.6.6 Techwell Recent Developments
11.7 GenSci
11.7.1 GenSci Corporation Information
11.7.2 GenSci Business Overview and Total Revenue (2019 VS 2018)
11.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 GenSci Follicle Stimulating Hormone Products and Services
11.7.5 GenSci SWOT Analysis
11.7.6 GenSci Recent Developments
11.8 Gedeon Richter
11.8.1 Gedeon Richter Corporation Information
11.8.2 Gedeon Richter Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Gedeon Richter Follicle Stimulating Hormone Products and Services
11.8.5 Gedeon Richter SWOT Analysis
11.8.6 Gedeon Richter Recent Developments
11.9 Teva
11.9.1 Teva Corporation Information
11.9.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Teva Follicle Stimulating Hormone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Teva Follicle Stimulating Hormone Products and Services
11.9.5 Teva SWOT Analysis
11.9.6 Teva Recent Developments 12 Supply Chain and Sales Channels Analysis 12.1 Supply Chain Analysis 12.2 Sales Channels Analysis
12.2.1 Follicle Stimulating Hormone Sales Channels
12.2.2 Follicle Stimulating Hormone Distributors
12.3 Follicle Stimulating Hormone Customers 13 Estimates and Projections by Regions (2021-2026)
13.1 Global Follicle Stimulating Hormone Sales Forecast (2021-2026)
13.1.1 Global Follicle Stimulating Hormone Sales Forecast by Regions (2021-2026)
13.1.2 Global Follicle Stimulating Hormone Revenue Forecast by Regions (2021-2026) 13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Follicle Stimulating Hormone Sales Forecast (2021-2026)
13.2.2 North America Follicle Stimulating Hormone Revenue Forecast (2021-2026)
13.2.3 North America Follicle Stimulating Hormone Size Forecast by County (2021-2026) 13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Follicle Stimulating Hormone Sales Forecast (2021-2026)
13.3.2 Europe Follicle Stimulating Hormone Revenue Forecast (2021-2026)
13.3.3 Europe Follicle Stimulating Hormone Size Forecast by County (2021-2026) 13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Follicle Stimulating Hormone Sales Forecast (2021-2026)
13.4.2 Asia Pacific Follicle Stimulating Hormone Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Follicle Stimulating Hormone Size Forecast by Region (2021-2026) 13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Follicle Stimulating Hormone Sales Forecast (2021-2026)
13.5.2 Latin America Follicle Stimulating Hormone Revenue Forecast (2021-2026)
13.5.3 Latin America Follicle Stimulating Hormone Size Forecast by County (2021-2026) 13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Follicle Stimulating Hormone Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Follicle Stimulating Hormone Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Follicle Stimulating Hormone Size Forecast by County (2021-2026) 14 Research Findings and Conclusion 15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Contact Us:-
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA – 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com
Web:
http://www.qyresearch.com
-
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Follicle Stimulating Hormone Market size was US$ 1357.7 million and is forecast to US$ 1816.7 million in 2026, growing at a CAGR of 4.2% from 2020 here
News-ID: 2151460 • Views: …
More Releases from QY Research
Low Calorie Desserts Market to Reach CAGR 7,8% by 2031 Top 10 Company Globally
The low calorie desserts industry covers ready-to-eat and ready-to-bake sweets formulated to offer indulgence with reduced calories, often achieved through reduced fat, reformulated recipes, portion control, or sugar alternatives. Products in the category span bakery desserts (light cakes, low-fat cookies), frozen desserts (low-calorie ice creams, frozen yogurt), and dairy-based desserts (light puddings, protein-rich cheesecakes). The category is driven by health-conscious consumption, rising incidence of diet-related conditions, growing demand for convenient…
Wafer Moisture Barrier Bag Market to Reach USD 5,150 Million by 2031 Top 20 Comp …
The wafer moisture barrier bag industry supplies specialized packaging designed to protect semiconductor wafers, die and sensitive electronic components from moisture ingress, particulate contamination and electrostatic discharge during storage and transport. These bags typically use metalized polyester (or composite multi-layer laminates) combined with polymer heat-seal layers and integrated desiccant/humidity indicator solutions to hold very low moisture vapor transmission rates (MVTR) while meeting ESD and cleanroom handling requirements. The segment sits…
Baby Video Monitoring Systems Market to Reach USD 2,181 Million by 2031 Top 20 C …
The global Baby Video Monitoring Systems industry provides hardware and connected-platform services that enable caregivers to remotely observe, hear, and increasingly track physiological and environmental signals for infants. This segment includes basic audio/video baby monitors, Wi-Fi/cloud-connected video monitors, and smart monitors that add breathing/sleep tracking, analytics, and smartphone apps.
The global 2024 baby video monitoring systems market size is USD 1,398 million in 2024 with an assumed CAGR of 6.5%…
Postbiotic Cosmetics for Skin Care Market to Reach USD 1,435 Million by 2031 Top …
Postbiotic cosmetics are a rapidly emerging sub-category of microbiome-oriented skincare that use non-viable microbial cells, metabolites and fermentation by-products (postbiotics) to support skin barrier function, hydration, inflammation control and overall microbiome balance. These ingredients are attractive to formulators because they combine biologically active benefits with heat- and shelf-stability not available from live probiotics, and they map directly onto consumer demand for science-backed, microbiome-safe products. Scientific literature and review articles highlight…
More Releases for Follicle
Breakthrough In The Follicle-Stimulating Hormone Market For Enhanced Infertility …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Follicle Stimulating Hormone Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for the follicle stimulating hormone (FSH) has seen robust growth in the recent past. It's projected to expand from $2.03 billion in 2024, increasing to $2.14 billion by 2025, at a…
Follicle Stimulating Hormone Market Overview: Analysis & Growth Forecast 2024-20 …
"The new report published by The Business Research Company, titled Follicle Stimulating Hormone Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the follicle stimulating hormone market size has grown strongly in recent years. It will grow from $1.94…
Follicle Aspiration Sets Market Analysis and Future Prospects for 2030
The world of the follicle aspiration sets market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing…
Global Follicle Stimulating Hormone Market Research Report 2023-2029
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Follicle Stimulating Hormone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Follicle Stimulating Hormone market is projected to reach US$ 1550.6 million in 2029, increasing from US$ 1275.1 million in 2022, with…
Urinary Follicle Stimulating Hormone Market: Competitive Dynamics & Global Outlo …
LP INFORMATION recently released a research report on the Urinary Follicle Stimulating Hormone market analysis, which studies the Urinary Follicle Stimulating Hormone's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Urinary Follicle Stimulating Hormone Market 2020-2025” Research Report categorizes the global Urinary Follicle Stimulating Hormone market by key players, product type, applications and regions,etc. The report also covers the latest…
Follicle Stimulating Hormone Market Global In-depth Analysis 2019
Global Follicle Stimulating Hormone Market reports are thorough analysis a careful investigation of around the world which enables the client to assess the long haul based request and predicts exact executions. The development rate which is really anticipated relying upon the scholarly examination gives thorough data on the overall Follicle Stimulating Hormone industry.
Access Full Information @ http://researchreport.biz/global-follicle-stimulating-hormone-market/
The drivers and restrictions are really assembled after the entire consciousness of the…
